K2 Principal Fund’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-46,377
Closed -$8.21M 349
2020
Q1
$8.21M Buy
46,377
+13,877
+43% +$2.61M 1.56% 18
2019
Q4
$6.21M Buy
32,500
+7,500
+30% +$1.35M 0.54% 54
2019
Q3
$4.21M Buy
25,000
+12,500
+100% +$2.04M 0.46% 76
2019
Q2
$2.09M Buy
+12,500
New +$1.73M 0.25% 137
2018
Q3
Sell
-4,500
Closed -$750K 403
2018
Q2
$750K Buy
+4,500
New +$722K 0.06% 240
2016
Q4
Sell
-18,311
Closed -$3.79M 352
2016
Q3
$4.22M Buy
18,311
+13,892
+314% +$3.39M 0.47% 62
2016
Q2
$1.02M Sell
4,419
-29,991
-87% -$6.91M 0.13% 128
2016
Q1
$9.22M Buy
34,410
+23,373
+212% +$6.69M 1.26% 20
2015
Q4
$3.45M Buy
11,037
+4,735
+75% +$1.41M 0.47% 61
2015
Q3
$1.71M Sell
6,302
-6,521
-51% -$2M 0.28% 76
2015
Q2
$3.89M Buy
12,823
+2,000
+18% +$597K 0.7% 39
2015
Q1
$3.22M Buy
+10,823
New +$3.09M 0.68% 42

Other funds holding AGN

K2 Principal Fund's AGN Position: Q2 2020 in Review

K2 Principal Fund sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 46,377 shares — an estimated $8.21M sold.

K2 Principal Fund first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $9.22M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • K2 Principal Fund reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • K2 Principal Fund sold 46,377 Allergan plc shares in Q2 2020, an estimated $8.21M.
  • K2 Principal Fund first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • K2 Principal Fund's Allergan plc position peaked at $9.22M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on K2 Principal Fund's 13F filing for Q2 2020, filed 13 Aug 2020.